Hexahydroazepinyloxy-chromones useful as antidepressants
    2.
    发明授权
    Hexahydroazepinyloxy-chromones useful as antidepressants 失效
    六氢吖辛氧基 - 色酮可用作抗抑郁药

    公开(公告)号:US4376123A

    公开(公告)日:1983-03-08

    申请号:US216454

    申请日:1980-12-15

    摘要: Basic ethers of the formula ##STR1## wherein Z is CH.sub.3 --NR.sup.2 --CH.sub.2 CH.sub.2 --CHR.sup.1 --, (1-R.sup.2 -3-piperidyl)-CHR.sup.3 --, (1-R.sup.2 -2-piperidyl)-CH.sub.2 --CHR.sup.3 - or 1-R.sup.2 -3-R.sup.4 -hexahydroazepinyl; R.sup.1 is cyclopropyl or Ar; R.sup.2 is H, alkyl of 1-4 C atoms, alkenyl of 2-4 C atoms, cycloalkylalkyl of 4-8 C atoms or benzyl; R.sup.3 is H or Ar; R.sup.4 is H or alkyl of 1-4 C atoms, Y is --O--CHQ.sup.1 --CHQ.sup.2 --CH.sub.2 --, --O--CHQ.sup.1 --CHQ.sup.2 --CO--, --O--CQ.sup.1 .dbd.CQ.sup.2 --CO-- or --CH.sub.2 --CHQ.sup.1 --CHQ.sup.2 --CO--; Q.sup.1 and Q.sup.2 are independently each H, alkyl of 1-4 C atoms, cycloalkyl or alkylcycloalkyl each of 3-6 total C atoms or Ar; and Ar is phenyl or phenyl substituted by F, Cl, alkoxy or alkylthio, each of 1-4 C atoms, methylenedioxy or CF.sub.3 ; with the proviso that when Z is (CH.sub.3 ).sub.2 N--CH.sub.2 CH.sub.2 --CHR.sup.1 in 7-position and Y is --O--C(C.sub.6 H.sub.5).dbd.CH--CO-- or --O--C(C.sub.6 H.sub.5).dbd.C(CH.sub.3)--CO--, R.sup.1 is cyclopropyl, or phenyl substituted by F, Cl, alkoxy or alkylthio, each of 1-4 C atoms, methylenedioxy or CF.sub.3 ;or a physiologically acceptable acid addition salt thereof, have valuable pharmacological properties, e.g., are antidepressants.

    摘要翻译: 其中Z为CH 3 -NR 2 -CH 2 CH 2 -CHR1-,(1-R2-3-哌啶基)-CHR3-,(1-R2-2-哌啶基)-CH2-CHR3-或1- R2-3-R4-六氢氮杂; R1是环丙基或Ar; R2是H,1-4个C原子的烷基,2-4个C原子的烯基,4-8个C原子的环烷基烷基或苄基; R3是H或Ar; R4是H或1-4个C原子的烷基,Y是-O-CHQ1-CHQ2-CH2-,-O-CHQ1-CHQ2-CO-,-O-CQ1 = CQ2-CO-或-CH2-CHQ1-CHQ2 -CO-; Q1和Q2各自独立地为H,1-4个C原子的烷基,3-6个总C原子或Ar的环烷基或烷基环烷基; 并且Ar是苯基或被F,Cl,烷氧基或烷硫基取代的苯基,各自为1-4个C原子,亚甲二氧基或CF 3; 条件是当Z为(CH3)2N-CH2CH2-CHR1为7-位,Y为-OC(C6H5)= CH-CO-或-OC(C6H5)= C(CH3)-CO-时,R1为环丙基 或被F,Cl,烷氧基或烷硫基取代的苯基,1-4C原子,亚甲二氧基或CF 3; 或其生理上可接受的酸加成盐具有有价值的药理学性质,例如抗抑郁药。

    Process for the treatment of fibrous materials with modified
organopolysiloxanes and the materials
    4.
    发明授权
    Process for the treatment of fibrous materials with modified organopolysiloxanes and the materials 失效
    用改性有机聚硅氧烷和材料处理纤维材料的方法

    公开(公告)号:US5196260A

    公开(公告)日:1993-03-23

    申请号:US892387

    申请日:1992-05-27

    IPC分类号: D06M15/356 D06N3/12

    摘要: The present invention relates to a process for the treatment of fibrous materials with modified organopolysiloxanes, wherein, in an aqueous medium, an organopolysiloxane copolymer prepared in a first stage from customary cyclic siloxanes (A) and unsaturated silanes (B) in the presence of a crosslinking agent and emulsifier (1) is copolymerized in a second stage with at least one vinyl monomer in the presence of emulsifiers (2), and the resulting dispersion of the modified organopolysiloxane copolymer is applied to the material in the customary manner and the material is dried and subjected to condensation.The process has the advantage that the materials, in particular textiles, treated by the process, above all coated by the process, have very good waterproof properties and at the same time good to very good water repellency. However, the materials are simultaneously distinguished by a pleasant soft handle, without the degree of whiteness thereof being noticeably impaired.

    摘要翻译: 本发明涉及一种用改性有机聚硅氧烷处理纤维材料的方法,其中在水性介质中,在常规环状硅氧烷(A)和不饱和硅烷(B)的第一阶段中制备的有机聚硅氧烷共聚物在 交联剂和乳化剂(1)在乳化剂(2)的存在下在第二阶段与至少一种乙烯基单体共聚,并且将所得改性的有机聚硅氧烷共聚物的分散体以常规方式施加到材料上,并且材料是 干燥并冷凝。 该方法的优点是,通过该方法处理的材料,特别是纺织品,首先通过该方法涂覆,具有非常好的防水性能,同时具有非常好的防水性。 然而,这些材料同时通过舒适的柔软手柄来区分,而白度却明显受损。

    Basic ethers useful as antidepressant agents
    5.
    发明授权
    Basic ethers useful as antidepressant agents 失效
    碱性醚可用作抗抑郁剂

    公开(公告)号:US4508732A

    公开(公告)日:1985-04-02

    申请号:US459928

    申请日:1983-01-21

    摘要: Basic ethers of the formula ##STR1## wherein Z is CH.sub.3 -NR.sup.2 -CH.sub.2 CH.sub.2 -CHR.sup.1 --, (1-R.sup.2 -3-piperidyl)-CHR.sup.3 --, (1-R.sup.2 -2-piperidyl)-CH.sub.2 -CHR.sup.3 -- or 1-R.sup.2 -3-R.sup.4 -- hexahydroazepinyl; R.sup.1 is cyclopropyl or Ar; R.sup.2 is H, alkyl of 1-4 C atoms, alkenyl of 2-4 C atoms, cycloalkylalkyl of 4-8 C atoms or benzyl; R.sup.3 is H or Ar; R.sup.4 is H or alkyl of 1-4 C atoms, Y is --O-CHQ.sup.1 -CHQ.sup.2 -CH.sub.2 --, --O-CHQ.sup.1 -CHQ.sup.2 -CO--, --O-CQ.sup.1 .dbd.CQ.sup.2 -CO-- or --CH.sub.2 -CHQ.sup.1 -CHQ.sup.2 -CO--; Q.sup.1 and Q.sup.2 are independently each H, alkyl of 1-4 C atoms, cycloalkyl or alkylcycloalkyl each of 3-6 total C atoms or Ar; and Ar is phenyl or phenyl substituted by F, Cl, alkoxy or alkylthio, each of 1-4 C atoms, methylenedioxy or CF.sub.3 ; with the proviso that when Z is (CH.sub.3).sub.2 N-CH.sub.2 CH.sub.2 -CHR.sup.1 in 7-position and Y is --O-C(C.sub.6 H.sub.5).dbd.CH-CO-- or --O-C(C.sub.6 H.sub.5).dbd.C(CH.sub.3)-CO--, R.sup.1 is cyclopropyl, or phenyl substituted by F, Cl, alkoxy or alkylthio, each of 1-4 C atoms, methylenedioxy or CF.sub.3 ; or a physiologically acceptable acid addition salt thereof, have valuable pharmacological properties, e.g., are antidepressants.

    摘要翻译: 其中Z为CH 3 -NR 2 -CH 2 CH 2 -CHR1-,(1-R2-3-哌啶基)-CHR3-,(1-R2-2-哌啶基)-CH2-CHR3-或1- R2-3-R4-六氢氮杂; R1是环丙基或Ar; R2是H,1-4个C原子的烷基,2-4个C原子的烯基,4-8个C原子的环烷基烷基或苄基; R3是H或Ar; R4是H或1-4个C原子的烷基,Y是-O-CHQ1-CHQ2-CH2 + 13,-O-CHQ1-CHQ2-CO-,-O-CQ1 = CQ2-CO-或-CH2-CHQ1- CHQ2-CO-; Q1和Q2各自独立地为H,1-4个C原子的烷基,3-6个总C原子或Ar的环烷基或烷基环烷基; 并且Ar是苯基或被F,Cl,烷氧基或烷硫基取代的苯基,各自为1-4个C原子,亚甲二氧基或CF 3; 条件是当Z为(CH3)2N-CH2CH2-CHR1为7-位,Y为-OC(C6H5)= CH-CO-或-OC(C6H5)= C(CH3)-CO-时,R1为环丙基 或被F,Cl,烷氧基或烷硫基取代的苯基,1-4C原子,亚甲二氧基或CF 3; 或其生理上可接受的酸加成盐具有有价值的药理学性质,例如抗抑郁药。

    Phenoxy heterocyclic amines and use thereof
    7.
    发明授权
    Phenoxy heterocyclic amines and use thereof 失效
    苯氧基杂环胺及其用途

    公开(公告)号:US4225608A

    公开(公告)日:1980-09-30

    申请号:US21277

    申请日:1979-03-16

    摘要: Phenoxyalkylamines of the formulaAr--O--Rwherein Ar is phenyl or phenyl which is monosubstituted or disubstituted by F, Cl, Br, alkyl or alkoxy each of 1-4 carbon atoms, cycloalkoxy of 3-6 carbon atoms, CF.sub.3, CN, alkylthio of 1-4 carbon atoms, SCF.sub.3, OH and/or alkanoyloxy with 1-10 carbon atoms; R is (1-R.sup.1 -2-pyrrolidyl)--CH.sub.2 --CHR.sup.2 --, (1-R.sup.1 -2-piperidyl)-CH.sub.2 --CHR.sup.2 -- or 1-R.sup.1 -3-Z-4-hexahydroazepinyl; R.sup.1 is H, alkyl or alkenyl each of up to 4 carbon atoms, cyclopropylmethyl or benzyl; R.sup.2 is H, alkyl of 1-4 carbon atoms or phenyl; and Z is alkyl of 1-4 carbon atoms with the proviso that Ar is p-fluorophenyl only if R is not 2-(1-methyl-2-piperidyl)-ethyl; and the physiologically acceptable acid addition salts thereof, possess valuable pharmacological properties, e.g., are antidepressants.

    摘要翻译: 式Ar-OR的苯氧基烷基胺其中Ar是苯基或被1-4个碳原子的F,Cl,Br,烷基或烷氧基单取代或二取代的苯基,3-6个碳原子的环烷氧基,CF 3,CN,烷硫基 1-4个碳原子,SCF 3,OH和/或具有1-10个碳原子的烷酰氧基; R 1是(1-R 1 - 吡咯烷基)-CH 2 -CHR 2 - ,(1-R 1 -2-哌啶基)-CH 2 -CHR 2 - 或1-R 1-3 -Z-4-六氢氮杂基; R1是H,最多4个碳原子的烷基或链烯基,环丙基甲基或苄基; R2是H,1-4个碳原子的烷基或苯基; 并且Z是1-4个碳原子的烷基,条件是仅当R不是2-(1-甲基-2-哌啶基) - 乙基时,Ar是对氟苯基; 及其生理上可接受的酸加成盐具有有价值的药理学性质,例如抗抑郁药。

    Tetralone and indanone compounds
    8.
    发明授权
    Tetralone and indanone compounds 失效
    四氢萘酮和茚酮化合物

    公开(公告)号:US4016281A

    公开(公告)日:1977-04-05

    申请号:US659132

    申请日:1976-02-18

    IPC分类号: C07D211/52

    CPC分类号: C07D211/52

    摘要: Tetralone and indanone compounds of the formula ##STR1## wherein R.sup.1 is H, OH, alkoxy of 1-4 carbon atoms, cycloalkoxy of 3-6 carbon atoms, F, Cl, Br, NO.sub.2, monoalkylamino or dialkylamino, wherein each alkyl is of 1-4 carbon atoms, alkanoyloxy of 1-6 carbon atoms or alkanoylamino of 1-4 carbon atoms; R.sup.2 is OH or alkoxy of 1-4 carbon atoms or R.sup.1 and R.sup.2 collectively are methylenedioxy; R.sup.3 is H or CH.sub.3 ; Ar is phenyl or phenyl substituted by up to 5 of alkyl of 1-4 carbon atoms, alkoxy of 1-4 carbon atoms, F, Cl, Br or CF.sub.3 ; n is 1 or 2, and physiologically acceptable acid addition salts thereof, are central nervous system depressants.

    摘要翻译: 其中R 1是H,OH,1-4个碳原子的烷氧基,3-6个碳原子的环烷氧基,F,Cl,Br,NO 2,一烷基氨基或二烷基氨基的四酮和茚酮化合物,其中每个烷基是 1-4个碳原子,1-6个碳原子的烷酰氧基或1-4个碳原子的烷酰氨基; R2是OH或1-4个碳原子的烷氧基或R1和R2统称为亚甲二氧基; R3是H或CH3; Ar是苯基或被至多5个1-4个碳原子的烷基,1-4个碳原子的烷氧基,F,Cl,Br或CF 3取代的苯基; n为1或2,其生理上可接受的酸加成盐为中枢神经系统抑制剂。

    Aminopropoxy-chromones useful as antidepressants
    9.
    发明授权
    Aminopropoxy-chromones useful as antidepressants 失效
    氨基丙氧基 - 色酮可用作抗抑郁药

    公开(公告)号:US4780478A

    公开(公告)日:1988-10-25

    申请号:US927559

    申请日:1986-11-06

    摘要: Basic ethers of the formula ##STR1## wherein Z is CH.sub.3 --NR.sup.2 --CH.sub.2 CH.sub.2 --CHR.sup.1 --, (1-R.sup.2 -3-piperidyl)-CHR.sup.3 --, (1-R.sup.2 -2-piperidyl)--CH.sub.2 --CHR.sup.3 -- or 1-R.sup.2 -3-R.sup.4 -hexahydroazepinyl; R.sup.1 is cyclopropyl or Ar; R.sup.2 is H, alkyl of 1-4 C atoms, alkenyl of 2-4 C atoms, cycloalkylalkyl of 4-8 C atoms or benzyl; R.sup.3 is H or Ar; R.sup.4 is H or alkyl of 1-4 C atoms, Y is --O--CHQ.sup.1 --CHQ.sup.2 --CH.sub.2 --, --O--CHQ.sup.1 --CHQ.sup.2 --CO--, --O--CQ.sup.1 .dbd.CQ.sup.2 --CO-- or --CH.sub.2 --CHQ.sup.1 --CHQ.sup.2 --CO--; Q.sup.1 and Q.sup.2 are independently each H, alkyl of 1-4 C atoms, cycloalkyl or alkylcycloalkyl each of 3-6 total C atoms or Ar; and Ar is phenyl or phenyl substituted by F, Cl, alkoxy or alkylthio, each of 1-4 C atoms, methylenedioxy or CF.sub.3 ; with the proviso that when Z is (CH.sub.3).sub.2 N--CH.sub.2 CH.sub.2 --CHR.sup.1 in 7-position and Y is --O--C(C.sub.6 H.sub.5).dbd.CH--CO-- or --O--C(C.sub.6 H.sub.5).dbd.C(CH.sub.3)--CO--, R.sup.1 is cyclopropyl, or phenyl substituted by F, Cl, alkoxy or alkylthio, each of 1-4 C atoms, methylenedioxy or CF.sub.3 ;or a physiologically acceptable acid addition salt thereof, have valuable pharmacological properties, e.g., are antidepressants.

    摘要翻译: 其中Z为CH 3 -NR 2 -CH 2 CH 2 -CHR1-,(1-R2-3-哌啶基)-CHR3-,(1-R2-2-哌啶基)-CH2-CHR3-或1- R2-3-R4-六氢氮杂; R1是环丙基或Ar; R2是H,1-4个C原子的烷基,2-4个C原子的烯基,4-8个C原子的环烷基烷基或苄基; R3是H或Ar; R4是H或1-4个C原子的烷基,Y是-O-CHQ1-CHQ2-CH2-,-O-CHQ1-CHQ2-CO-,-O-CQ1 = CQ2-CO-或-CH2-CHQ1-CHQ2 -CO-; Q1和Q2各自独立地为H,1-4个C原子的烷基,3-6个总C原子或Ar的环烷基或烷基环烷基; 并且Ar是苯基或被F,Cl,烷氧基或烷硫基取代的苯基,各自为1-4个C原子,亚甲二氧基或CF 3; 条件是当Z为(CH3)2N-CH2CH2-CHR1为7-位,Y为-OC(C6H5)= CH-CO-或-OC(C6H5)= C(CH3)-CO-时,R1为环丙基 或被F,Cl,烷氧基或烷硫基取代的苯基,1-4C原子,亚甲二氧基或CF 3; 或其生理上可接受的酸加成盐具有有价值的药理学性质,例如抗抑郁药。